Cargando…
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?
In patients with clinical stage I non-seminomatous testicular cancer only limited information is available about the administrative problems with the surveillance programme, in particular if this policy is to be implemented in a geographically extended country with limited computerised tomography (C...
Autores principales: | Fosså, S. D., Jacobsen, A. B., Aass, N., Heilo, A., Stenwig, A. E., Kummen, O., Johannessen, N. B., Waaler, G., Ogreid, P., Borge, L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033670/ https://www.ncbi.nlm.nih.gov/pubmed/7981068 |
Ejemplares similares
-
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
por: Jacobsen, K D, et al.
Publicado: (1999) -
Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor
por: Xavier, Rosana, et al.
Publicado: (2020) -
Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94.
por: Dueland, S., et al.
Publicado: (1998) -
Distinct Proteomic Profile of Spermatozoa from Men with Seminomatous and Non-Seminomatous Testicular Germ Cell Tumors
por: Panner Selvam, Manesh Kumar, et al.
Publicado: (2020) -
Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
por: Hernes, E. H., et al.
Publicado: (1997)